| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |